Inventor · disambiguated record
Olaf Ritzeler
Also filed as: RITZELER OLAF
18 granted patents·10 pending applications·314 citations·filing 2000–2025
94Inventor score
Files withSANOFI SA13SANOFI AVENTIS DEUTSCHLAND5AVENTIS PHARMA GMBH4AVENTIS PHARMA INC1BARONI MARCO1
Top patents by PatentIndex Score
28 records- 0197US6358978B1Substituted benzimidazolesAVENTIS PHARMA GMBH·Filed 2000·Granted Mar 19, 2002·203 cites·28 claims
- 0289US6627637B2Substituted beta carbolinesAVENTIS PHARMA GMBH·Filed 2001·Granted Sep 30, 2003·38 cites·38 claims
- 0388US11827633B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2021·Granted Nov 28, 2023·1 cites·17 claims
- 0485US7348336B2Substituted β-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted Mar 25, 2008·6 cites·22 claims
- 0584US12275733B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2023·Granted Apr 15, 2025·0 cites·9 claims
- 0684US8809358B2Use of IκB-kinase inhibitors in pain therapyMICHAELIS MARTIN·Filed 2008·Granted Aug 19, 2014·5 cites·4 claims
- 0784US7342029B2Substituted indolesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Mar 11, 2008·6 cites·8 claims
- 0883US7285560B2Indole derivatives or benzimidazole derivatives for modulating IκB kinaseSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Oct 23, 2007·17 cites·6 claims
- 0982US7462638B2Use of IκB-kinase inhibitors in pain therapySANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Dec 9, 2008·15 cites·3 claims
- 1079US11130755B2Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2017·Granted Sep 28, 2021·2 cites·12 claims
- 1176US7026331B2Substituted beta-carbolinesSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Apr 11, 2006·7 cites·22 claims
- 1275US8912224B2Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticalsCZECHTIZKY WERNGARD·Filed 2011·Granted Dec 16, 2014·3 cites·20 claims
- 1375US8778955B2Indole derivatives or benzimidazole derivatives for modulating IkB kinaseRITZELER OLAF·Filed 2007·Granted Jul 15, 2014·4 cites·4 claims
- 1473US2025333412A1Substituted pyrido[3,4-b]indoles for the treatment of cartilage disordersSANOFI SA·Filed 2025·Application pending·0 cites
- 1572US9440941B2Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticalsSANOFI SA·Filed 2014·Granted Sep 13, 2016·2 cites·18 claims
- 1668US9126972B22-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitorsBRAUN ALAIN·Filed 2012·Granted Sep 8, 2015·3 cites·19 claims
- 1768US9067918B2Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amideSANOFI SA·Filed 2012·Granted Jun 30, 2015·2 cites·20 claims
- 1859US2015087648A1Subsituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticalsSANOFI SA·Filed 2014·Application pending·0 cites
- 1954US2018148440A1Substituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticalsSANOFI SA·Filed 2017·Application pending·0 cites
- 2054US2004209868A1Substituted indolesAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 2151US2017037042A1Substituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticalsSANOFI SA·Filed 2016·Application pending·0 cites
- 2250US2003119820A1Substituted indolesAVENTIS PHARMA GMBH·Filed 2002·Application pending·0 cites
- 2350US2017050988A1Dotam derivatives for therapeutic useSANOFI SA·Filed 2014·Application pending·0 cites
- 2448US2007142417A1Substantially Pure 2-{[2-(2-Methylamino-Pyrimidin-4-YL)-1H-Indole-5-Carbonyl]-Amino}-3-Phenylpyridin-2-YL-Amino)-Propionic Acid as an IkB Kinase InhibitorAVENTIS PHARMA INC·Filed 2006·Application pending·0 cites
- 2545US2017166548A1Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticalsSANOFI SA·Filed 2017·Application pending·0 cites
- 2641US2014243292A1Subsituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticalsSANOFI SA·Filed 2014·Application pending·0 cites
- 2740US9675606B22-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitorsSANOFI SA·Filed 2015·Granted Jun 13, 2017·0 cites·17 claims
- 2834US8153637B2Phenyl-alkyl piperazines having TNF-modulating activity, preparation method, and therapeutic use thereofBARONI MARCO·Filed 2010·Granted Apr 10, 2012·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →